Adenosine vs Diltiazem for Treatment of SVT in the ED

Recruiting now · Phase 4

Conditions studied: Supraventricular Tachycardia (SVT)

In brief

This is a small, pilot study with a primary goal of assessing patient perceptions of two medication treatments for supraventricular tachycardia in adult patients treated in the Emergency Department.

Key facts

Study ID

NCT06993038

Run by

Anne E. Zepeski

People needed

20

Starts

2025-08-01

Expected to finish

2027-12-01

Last updated by the study team

2026-05-28

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients (18 years and older)
• Diagnosis of acute, stable SVT in the emergency department

You may not qualify if…

• Receipt of IV AV-nodal blocking agents prior to study enrollment (includes adenosine, non-dihydropyridine calcium channel blockers, beta-antagonists in pre-hospital and/or hospital setting).
• Reported or confirmed personal history of Wolff-Parkinson-White (WPW) syndrome
• History of heart failure with reduce ejection fraction (HFrEF) (LVEF</= 40%)
• Severe bronchoconstrictive lung disease
• Prior hypersensitivity to study medication
• Previously enrolled in pilot study
• Pregnant
• Incarcerated

Where it is running

• University of Iowa Health Care — Iowa City, Iowa, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.